Lanphier is a moral philosopher and clinical ethicist specializing. Her scholarship is centered around shared and collective responsibility, especially related to health care justice. Lanphier’s research focuses on projects related to health care access, reproductive justice, medical and sexual consent and decision-making, trauma informed care, narrative practices in medicine, incarceration and health, and clinical ethics consultation. In addition to her research and scholarship, Lanphier is a clinical ethics consultant at Cincinnati Children’s Hospital Medical Center, providing ethical support and analysis in direct patient care.
In the News
Discusses the FDA's approval of Opill, a progestin-only norgestrel tablet, for over-the-counter (OTC) access. Emphasizes that while OTC oral contraceptives can enhance accessibility and decrease unplanned pregnancies, they are not a complete solution to post-Dobbs abortion restrictions. Argues that clinicians must maximize the benefits of OTC contraceptives while continuing to advocate for safe and accessible abortion care.